首页> 外文OA文献 >The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients

【2h】

The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients

机译：Mineralocorcoid受体拮抗剂Canronons在Covid-19患者中的疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Marco Vicenzi; Massimiliano Ruscica; Simona Iodice; Irene Rota; Angelo Ratti; Roberta Di Cosola; Alberto Corsini; Valentina Bollati; Stefano Aliberti; Francesco Blasi;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Mineralcorticoid Receptor Antagonist Withdrawal for Hyperkalemia and Mortality in Patients with Heart Failure [J] . Lisi F., Parisi G., Gioia M.I., Cardiorenal medicine . 2020,第3期

机译：Mineralocorcoid受体拮抗性患者戒除心力衰竭患者的高钾血症和死亡率
2. Mineralcorticoid Receptor Antagonist Withdrawal for Hyperkalemia and Mortality in Patients with Heart Failure [J] . Cardiorenal medicine . 2020,第3期

机译：Mineralocorcoid受体拮抗性患者戒除心力衰竭患者的高钾血症和死亡率
3. Biotransformation of the mineralocorticoid receptor antagonists spironolactone and canrenone by human CYP11B1 and CYP11B2: Characterization of the products and their influence on mineralocorticoid receptor transactivation [J] . Schiffer Lina, Mueller Anne-Rose, Hobler Anna, The Journal of Steroid Biochemistry and Molecular Biology . 2016,第Null期

机译：CYP11B1和CYP11B2对盐皮质激素受体拮抗剂螺内酯和烯睾丙内酯的生物转化：产物的表征及其对盐皮质激素受体反式激活的影响
4. Comparative study of recombinant human interleukin-1 receptor antagonist for the treatment of patients with psoriatic and rheumatoid arthrites [C] . Ischenko A., Kleymenova I., Raymuev K., Joint Conferences of the International Cytokine Society and the International Society for Interferon and Cytokine Research . 2011

机译：重组人白细胞介素-1受体拮抗剂治疗银屑病和类风湿性术患者的比较研究
5. Utilization of Vasopressin as a First Line Response to Perioperative Hypotension in the Patient on Angiotensin Receptor Antagonists and Angiotensin Converting Enzyme Inhibitors [D] . Buckley, Emily A. 2015

机译：利用血管加压素作为对围手术期低血压患者的血管紧张素受体拮抗剂和血管紧张素转化酶抑制剂的一线反应
6. The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients [O] . Marco Vicenzi, Massimiliano Ruscica, Simona Iodice, 2020

机译：Mineralocorcoid受体拮抗剂Canronons在Covid-19患者中的疗效
7. Efficacy and Safety of Two Dosages of Canrenone as Add-On Therapy in Hypertensive Patients Taking Ace-Inhibitors or Angiotensin II Receptor Blockers and Hydrochlorothiazide at Maximum Dosage in a Randomized Clinical Trial: The ESCAPE-IT Trial [O] . Derosa, Giuseppe, Maffioli, Pamela, D'Avino, Maria, 2016

机译：两种剂量的坎利酮作为高血压患者的附加疗法的有效性和安全性在随机临床试验中服用最大剂量的ace抑制剂或血管紧张素II受体阻滞剂和氢氯噻嗪：EsCapE-IT试验
8. Efficacy of the GluK1/AMPA Receptor Antagonist LY293558 against Seizures and Neuropathology in a Soman-Exposure Model without Pretreatment and its Pharmacokinetics after Intramuscular Administration. [R] . Apland, J. P., Aroniadou-Anderjaska, V., Figueiredo, T. H., 2013

机译：GluK1 / ampa受体拮抗剂LY293558在未经预处理的soman暴露模型中对癫痫发作和神经病理学的影响及其在肌内给药后的药代动力学。

The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients

著录项

引文网络

相似文献

相关主题

期刊订阅